£66.04

Biomarkers for Early Diagnosis of Alzheimer's Disease

Neurology & Clinical Neurophysiology

Price data last checked 14 day(s) ago - will refresh soon

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

About as cheap as it gets. The only time it was cheaper was 1 month ago.

£66 today · all-time low £66 (Jun 2026) · usually £66

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 77 days · 77 data points (no recent data)

Historical

Generating forecast…

Price Distribution

Price distribution over 77 days • 1 price levels

Days at Price

Price Analysis

Most common price: £66 (77 days, 100.0%)

Price range: £66 - £66

Price levels: 1 different prices over 77 days

Description

Alzheimer's disease (AD) is characterized by the deposition into the brain of amyloid peptide, which originates a cascade of inflammatory events leading eventually to neuronal death. These pathological events likely occur several years before the clinical manifestation of the disease, implying that potential therapeutical interventions are currently started too late to give beneficial results. Recently, growing attention has been paid to the Mild Cognitive Impairment (MCI), considered the prodromal phase of AD, as 80% of subjects with MCI have been shown to develop AD within 5 years. Several studies aimed to identify biological markers to differentiate between normal aging and incipient AD have been carried out, including cerebrospinal fluid (CSF) analysis and neuroimaging. In particular, the evaluation of CSF Amyloid beta (1-42) levels, together with tau and phospotau, are of help for recognizing early AD. Besides, a number of additional molecules are altered in CSF. Other early modifications have been observed in peripheral cells, such as fibroblasts and leukocytes, as well as in serum from patients. Biomarkers for AD represent important tools supporting the clinical diagnosis and the choice of potential therapeutic options. Moreover, they would be of great help for the selection of cohorts of homogeneous patients for clinical trials with new disease-modifying compounds. This book is aimed to give an update about MCI as prodromal Alzheimer's disease (AD), to discuss the main known pathological mechanisms at the basis of AD and to describe the possible biomarkers to be used for an early diagnosis of the disease.

Key Features

New

Mint Condition

Dispatch same day for order received before 12 noon

Guaranteed packaging

No quibbles returns

Product Specifications

Format: hardcover
ASIN: 1604569913
Category: Books > Subjects > Health, Family & Lifestyle > Medical & Healthcare Practitioners > Internal Medicine > Neurology & Clinical Neurophysiology
Domain: Amazon UK
Release Date: 01 December 2008
Listed Since: 19 July 2010

Barcode

No barcode data available

Biomarkers for Early Diagnosis of Alzheimer's Disease

About as cheap as it gets. The only time it was cheaper was 1 month ago.

Price History & Forecast

Price Distribution

Price Analysis

Description

Key Features

Product Specifications

Barcode

Similar Products You Might Like

Alzheimer's Diagnosis (Neuroscience Research Progress)

Biomarkers for Preclinical Alzheimer’s Disease: 137 (Neuromethods, 137)

Alzheimer's Disease: Targets for New Clinical Diagnostic and Therapeutic Strategies (Frontiers in Neuroscience)

Alzheimer's Disease and Frontotemporal Dementia: Methods and Protocols: 670 (Methods in Molecular Biology, 670)

ALZHEIMER'S DISEASE: INSIGHTS INTO LOW MOLECULAR WEIGHT AND CYTOTOXIC AGGREGATES FROM IN VITRO AND COMPUTER EXPERIMENTS - MOLECULAR BASIS OF ... (Molecular Medicine And Medicinal Chemistry)

The End of Alzheimer's: The Brain and Beyond

Research Progress in Alzheimer's Disease & Dementia: v. 4 (Research Progress in Alzheimer's Disease and Dementia): Volume 4

Clinical Diagnosis and Management of Alzheimer's Disease

Neuroprotection in Alzheimer's Disease

Alzheimer's Disease: Biology, Biophysics And Computational Models

Molecular Mechanisms of Dementia (Contemporary Neuroscience)

Early Detection of Alzheimer’s Disease: Biological and Technological Advances

A New Era in Alzheimer's Research: Pathogenesis, Prevention, and Treatment

Neuroanatomy and Pathology of Sporadic Alzheimer's Disease: 215 (Advances in Anatomy, Embryology and Cell Biology, 215)

Alzheimer's Disease in the Middle-Aged

Alzheimer’s Disease Estimation: A Pattern Recognition based Approach using MRI and Genotype Data

Alzheimer’s Disease: Lessons from Cell Biology (Research and Perspectives in Alzheimer's Disease)

Alzheimer's Disease: Risk Factors, Diagnosis, Coping & Support (Neurology - Laboratory and Clinical Research Developments)

Young-Onset Dementias, An Issue of Psychiatric Clinics of North America (Volume 38-2) (The Clinics: Internal Medicine, Volume 38-2)